Alpha 2.0
Login Register
» Articles » PMID: 25136212

Platelet-rich Plasma in Androgenic Alopecia: Myth or an Effective Tool

Overview
Journal J Cutan Aesthet Surg
Date 2014 Aug 20
PMID 25136212
Citations 37
Authors
Swapna S Khatu
Yuvraj E More
Neeta R Gokhale
Dipali C Chavhan
Nitin Bendsure
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Platelet-rich plasma (PRP) has become a newer method for the treatment of various types of alopecia. In this prospective study, safety, efficacy and feasibility of PRP injections in treating androgenic alopecia were assessed. Eleven patients suffering from hair loss due to androgenic alopecia and not responding to 6 months treatment with minoxidil and finasteride were included in this study. The hair pull test was performed before every treatment session. A total volume of 2-3 cc PRP was injected in the scalp by using an insulin syringe. The treatment was repeated every two weeks, for a total of four times. The outcome was assessed after 3 months by clinical examination, macroscopic photos, hair pull test and patient's overall satisfaction.

Results: A significant reduction in hair loss was observed between first and fourth injection. Hair count increased from average number of 71 hair follicular units to 93 hair follicular units. Therefore, average mean gain is 22.09 follicular units per cm(2.) After the fourth session, the pull test was negative in 9 patients.

Conclusion: PRP injection is a simple, cost effective and feasible treatment option for androgenic alopecia, with high overall patient satisfaction.

Citing Articles

Greater Trochanteric Pain Syndrome and the Efficacy of Platelet-Rich Plasma Injections: A Systematic Review.

Ahmed H, Tarar M, Khalid A, Shah N, Gilani A, Ijaz M Cureus. 2024; 16(10):e72597.

PMID: 39610638 PMC: 11604237. DOI: 10.7759/cureus.72597.

Therapeutic Potential of Adipose-Derived Stem Cells and Their Secretome in Reversible Alopecias: A Systematic Review.

Ortega-Cuartiella A Int J Trichology. 2024; 15(5):173-182.

PMID: 39170092 PMC: 11335044. DOI: 10.4103/ijt.ijt_3_21.

Clinical and preclinical approach in AGA treatment: a review of current and new therapies in the regenerative field.

Pozo-Perez L, Tornero-Esteban P, Lopez-Bran E Stem Cell Res Ther. 2024; 15(1):260.

PMID: 39148125 PMC: 11328498. DOI: 10.1186/s13287-024-03801-5.

Revitalizing Hair Growth: A New Regimen Utilizing Growth Factor Concentrate for Hair Loss Treatment.

Bhargava A, Singh V, Tiwari R, Arya A, Chokshi K Cureus. 2024; 16(6):e63354.

PMID: 39070330 PMC: 11283646. DOI: 10.7759/cureus.63354.

Aesthetic Rehabilitation Medicine: Enhancing Wellbeing beyond Functional Recovery.

Lippi L, Ferrillo M, Losco L, Folli A, Marcasciano M, Curci C Medicina (Kaunas). 2024; 60(4).

PMID: 38674249 PMC: 11052208. DOI: 10.3390/medicina60040603.

References
1.
Sunitha Raja V, Naidu E . Platelet-rich fibrin: evolution of a second-generation platelet concentrate. Indian J Dent Res. 2008; 19(1):42-6. DOI: 10.4103/0970-9290.38931. View
2.
Messenger A . Medical management of male pattern hair loss. Int J Dermatol. 2000; 39(8):585-6. DOI: 10.1046/j.1365-4362.2000.00019.x. View
3.
Glover J, Weingarten M, Buchbinder D, POUCHER R, Deitrick 3rd G, Fylling C . A 4-year outcome-based retrospective study of wound healing and limb salvage in patients with chronic wounds. Adv Wound Care. 1997; 10(1):33-8. View
4.
Olsen E, Weiner M, DeLong E, Pinnell S . Topical minoxidil in early male pattern baldness. J Am Acad Dermatol. 1985; 13(2 Pt 1):185-92. DOI: 10.1016/s0190-9622(85)70157-0. View
5.
Gardner M, Demetrakopoulos D, Klepchick P, Mooar P . The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty. An analysis of the haemoglobin, narcotic requirement and range of motion. Int Orthop. 2006; 31(3):309-13. PMC: 2267605. DOI: 10.1007/s00264-006-0174-z. View